Baird Medical Investment Holdings Limited (BDMD) Stock Price & Analysis
Baird Medical Investment Holdings Limited (BDMD) closed at USD 0.6 on Thursday, October 15, 2026, up 8.99% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.55; the Oct 15, 2026 session ranged USD 0.55–0.62 on volume of 79,879 shares. Market capitalization is $19.27M, with a 52-week range of USD 0.51–3.7 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BDMD.md
Key facts (BDMD)
- Analysts: None (1 analysts), mean target USD 4 (range 4–4).
- Total return with dividends: 1Y -61.3% vs S&P 500 +18.1%; 5Y -93.8% vs S&P 500 +85.1%.
Analysts (BDMD)
Consensus None, 1 analysts; mean target USD 4 (low 4, high 4).
Total return (dividends reinvested) (BDMD)
| 1Y (from 2025-10-16) | 5Y (from 2021-12-13) | |
|---|---|---|
| Total return | -61.3% | -93.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -61.4% | -43.8% |
| Volatility (annualized) | 109.6% | 107.2% |
| Max drawdown | -84.0% (Mar 2026→Oct 2026) | -94.8% (Sep 2024→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 0.6 |
|---|---|
| Change | ▲ 8.99% (up) |
| Previous Close | USD 0.55 |
| Open | USD 0.55 |
| Day Range | USD 0.55 – 0.62 |
| 52-Week Range | USD 0.51 – 3.7 |
| Volume | 79,879 shares |
| Market Cap | $19.27M |
| Exchange | NCM |
Technical Analysis (BDMD)
Nexqual's technical model rates BDMD "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:11 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 25.93 (oversold) |
| vs SMA50 | Below (USD 0.99) |
| MACD | -0.1 (negative) |
Analyst Ratings (BDMD)
Wall Street analysts rate BDMD "None" based on 1 analysts, with a mean price target of USD 4 (range USD 4–4), per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 4 |
| High Target | USD 4 |
| Low Target | USD 4 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (BDMD)
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financials & Fundamentals (BDMD)
| Total Revenue | $24.49M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +24.60% |
| Gross Margin | +85.63% |
| Operating Margin | +8.54% |
| Profit Margin | -65.12% |
| ROE | -46.03% |
| Debt / Equity | 0.55 |
| Current Ratio | 1.29 |
| Total Cash | $397,194 |
| Total Debt | $18.88M |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Ownership (BDMD)
| Insider Ownership | +86.31% |
|---|---|
| Institutional Ownership | +0.99% |
| Shares Outstanding | 32.11M |
| Float | 12.67M |
| Short % of Float | +0.30% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Leadership (BDMD)
Baird Medical Investment Holdings Limited is led by Haimei Wu (age 43), Chairwoman of the Board of Directors & CEO, per Nexqual as of October 16, 2026 at 05:11 UTC.
| Chairwoman of the Board of Directors & CEO | Haimei Wu (age 43) |
|---|---|
| Chief Administrative Officer & Executive Director | Quan Qiu (age 32) |
| Executive Director | Wei Hou (age 55) |
| Acting Chief Financial Officer | Jie Li (age 37) |
| CTO & Deputy GM | Rongjian Lu (age 58) |
Major Backers & Investors (BDMD)
Notable institutional backers of Baird Medical Investment Holdings Limited include UBS Group AG, Renaissance Technologies, Two Sigma Investments, LP, according to Nexqual as of October 16, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| UBS Group AG | 0.14% |
| Renaissance Technologies | 0.13% |
| Two Sigma Investments, LP | 0.13% |
| Citadel | 0.13% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ESTA | Establishment Labs Holdings Inc | USD 61.36 | ▲ 4.98% |
| ALMR | Alamar Biosciences, Inc. | USD 27.42 | ▲ 16.58% |
| INSP | Inspire Medical Systems, Inc. | USD 70.12 | ▲ 1.83% |
| BFLY | Butterfly Network, Inc. | USD 7.85 | ▼ 3.09% |
| AXGN | AxoGen, Inc. | USD 35.63 | ▼ 1.49% |
| UFPT | UFP Technologies, Inc. | USD 297.19 | ▲ 0.99% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt